Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis
暂无分享,去创建一个
[1] S. Garattini,et al. Non-inferiority trials are unethical because they disregard patients' interests , 2007, The Lancet.
[2] J. Saurat,et al. Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION) , 2007, The British journal of dermatology.
[3] Å. Svensson,et al. Methotrexate vs. ciclosporin in psoriasis: effectiveness, quality of life and safety. A randomized controlled trial , 2007, The British journal of dermatology.
[4] P. Bossuyt,et al. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. , 2003, The New England journal of medicine.